ResearcherYale UniversityActive in the last 2 years

Christian Felipe Ruiz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1470-8061; OpenAlex author ID A5083379418, A5132865818. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. Co-author DOI 10.1038/s41467-026-69821-2 ↗
Decoding the obesity-cancer connection: lessons from preclinical models of pancreatic adenocarcinoma. Co-author DOI 10.26508/lsa.202302228 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cathy C. Garcia · 2 shared papers, 2023–2026 · strength 0.48
- Paper Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. DOI 10.1038/s41467-026-69821-2 ↗
- Paper Decoding the obesity-cancer connection: lessons from preclinical models of pancreatic adenocarcinoma. DOI 10.26508/lsa.202302228 ↗
Mandar Deepak Muzumdar · 2 shared papers, 2023–2026 · strength 0.48
- Paper Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. DOI 10.1038/s41467-026-69821-2 ↗
- Paper Decoding the obesity-cancer connection: lessons from preclinical models of pancreatic adenocarcinoma. DOI 10.26508/lsa.202302228 ↗
Akin Sogunro · 1 shared paper, 2026 · strength 0.24
- Paper Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development. DOI 10.1038/s41467-026-69821-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.